TUMENTIA RESEARCH
Tumentia is a pharmaceutical company focused on the development of new therapies for cancer patients. The company was founded by graduates of the Concordia University in Montreal, Canada & the University of Wyoming in 2014. We develop novel therapies for cancer patients. Our research has resulted in five pre-clinical stage drugs that treat different types of cancers. Tumentia has been acquired by Excellence Health Inc. in October, 2017 & will now operate as a subsidiary.
TUMENTIA RESEARCH
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
Casper, Wyoming, United States
Country:
United States
Website Url:
http://www.tumentia.com
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Nginx Amazon CloudFront OpenResty Google Adsense AWS Global Accelerator
Similar Organizations
MirImmune
MirImmune is a biopharmaceutical company focused on the development of new and improved immunotherapies for cancer.
Swiss Rockets
Swiss Rockets focuses on the development of new treatment therapies and clinical drugs for cancer patients.
